CA3231261A1 - Acetylated sialic acid glycoclusters and their uses for treating infectious diseases - Google Patents
Acetylated sialic acid glycoclusters and their uses for treating infectious diseases Download PDFInfo
- Publication number
- CA3231261A1 CA3231261A1 CA3231261A CA3231261A CA3231261A1 CA 3231261 A1 CA3231261 A1 CA 3231261A1 CA 3231261 A CA3231261 A CA 3231261A CA 3231261 A CA3231261 A CA 3231261A CA 3231261 A1 CA3231261 A1 CA 3231261A1
- Authority
- CA
- Canada
- Prior art keywords
- acetylated
- glycocluster
- sialic acid
- cov
- sars
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/545—Heterocyclic compounds
- A61K47/546—Porphyrines; Porphyrine with an expanded ring system, e.g. texaphyrine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H23/00—Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21195975.4 | 2021-09-10 | ||
| EP21195975 | 2021-09-10 | ||
| PCT/EP2022/075109 WO2023036932A1 (en) | 2021-09-10 | 2022-09-09 | Acetylated sialic acid glycoclusters and their uses for treating infectious diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3231261A1 true CA3231261A1 (en) | 2023-03-16 |
Family
ID=77710644
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3231261A Pending CA3231261A1 (en) | 2021-09-10 | 2022-09-09 | Acetylated sialic acid glycoclusters and their uses for treating infectious diseases |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250134921A1 (https=) |
| EP (1) | EP4398940A1 (https=) |
| JP (1) | JP2024533417A (https=) |
| KR (1) | KR20240109239A (https=) |
| CN (1) | CN118613285A (https=) |
| CA (1) | CA3231261A1 (https=) |
| WO (1) | WO2023036932A1 (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120192635A (zh) * | 2025-05-26 | 2025-06-24 | 杭州之江有机硅化工有限公司 | 一种机械互锁环氧树脂聚合物及其制备方法和应用 |
-
2022
- 2022-09-09 CN CN202280071624.5A patent/CN118613285A/zh active Pending
- 2022-09-09 WO PCT/EP2022/075109 patent/WO2023036932A1/en not_active Ceased
- 2022-09-09 JP JP2024515553A patent/JP2024533417A/ja active Pending
- 2022-09-09 EP EP22785933.7A patent/EP4398940A1/en active Pending
- 2022-09-09 KR KR1020247011675A patent/KR20240109239A/ko active Pending
- 2022-09-09 CA CA3231261A patent/CA3231261A1/en active Pending
- 2022-09-09 US US18/690,372 patent/US20250134921A1/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120192635A (zh) * | 2025-05-26 | 2025-06-24 | 杭州之江有机硅化工有限公司 | 一种机械互锁环氧树脂聚合物及其制备方法和应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024533417A (ja) | 2024-09-12 |
| US20250134921A1 (en) | 2025-05-01 |
| CN118613285A (zh) | 2024-09-06 |
| WO2023036932A1 (en) | 2023-03-16 |
| EP4398940A1 (en) | 2024-07-17 |
| KR20240109239A (ko) | 2024-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2016323377B2 (en) | Carbohydrate ligands that bind to antibodies against glycoepitopes of glycosphingolipids | |
| Marra et al. | Synthesis of sialoclusters appended to calix [4] arene platforms via multiple azide-alkyne cycloaddition. New inhibitors of hemagglutination and cytopathic effect mediated by BK and influenza A viruses | |
| US20070185040A1 (en) | Guanidinium derivatives for improved cellular transport | |
| JP6661643B2 (ja) | 重合胆汁酸誘導体によるｂ型肝炎ウイルス及びｄ型肝炎ウイルスとｎｔｃｐ輸送の阻害 | |
| WO2023088382A1 (zh) | 抗体-药物偶联物及其用途 | |
| CZ294096A3 (en) | Piperidine- and pyrrolidinecarboxylic acids, process of their preparation and their use for preparing medicaments and diagnostic preparations | |
| PT1934236E (pt) | Inibidores de pan-selectina heterobifuncionais | |
| CN109939242B (zh) | 抗体前药偶联物及其制备和应用 | |
| CA3140411C (en) | Saponin conjugate and vaccine or pharmaceutical composition comprising the same | |
| CA3202303C (en) | Trop2 targeting antibody-drug conjugate, and preparation method and use therefor | |
| JP6295202B2 (ja) | 感染性疾患の予防および治療のために有用なマンノシル化された化合物 | |
| EP0374888A3 (en) | Sulfated tannins and theirs salts | |
| CA3231261A1 (en) | Acetylated sialic acid glycoclusters and their uses for treating infectious diseases | |
| US7799768B2 (en) | Polymorphs of 3-O-(3′,3′-dimethylsuccinyl)betulinic acid di-N-methyl-D-glucamine | |
| WO2019054379A1 (ja) | オレアノール酸誘導体 | |
| TW202334176A (zh) | 新穎的澳瑞他汀(auristatin)類似物及其免疫綴合物 | |
| Bachan et al. | Synthesis, gp120 binding and anti-HIV activity of fatty acid esters of 1, 1-linked disaccharides | |
| FR2774989A1 (fr) | Nouveaux cytotoxiques derives de l'oestradiol | |
| CN121927068A (zh) | 一种靶向gpc3的抗体药物偶联物及其用途 | |
| CN118059091A (zh) | 复合烯二炔作为广谱抗冠状病毒药物的应用 | |
| US20160228565A1 (en) | Polyamide based peptidodendrimer conjugates |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 2ND ANNIV.) - STANDARD Year of fee payment: 2 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20240909 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20240909 Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20240909 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD Year of fee payment: 3 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250901 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250901 |